Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
JAMA|February 14, 2022
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant PredominanceAmadea Britton, Katherine E Fleming-Dutra, Nong Shang, et al.
The American Journal of Clinical Nutrition|August 9, 2022
Long-term diet and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and Coronavirus Disease 2019 (COVID-19) severityYiyang Yue, Wenjie Ma, Emma K Accorsi, et al.
Genome Biology|December 14, 2020
Determinants of Staphylococcus aureus carriage in the developing infant nasal microbiomeEmma K Accorsi, Eric A Franzosa, Tiffany Hsu, et al.
Open Forum Infectious Diseases|May 22, 2023
Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant PeriodsAllison Avrich Ciesla, Ryan E Wiegand, Zachary R Smith, et al.
Disability and Health Journal|February 5, 2023
Post-COVID conditions and healthcare utilization among adults with and without disabilities-2021 Porter Novelli FallStyles surveyMaureen J Miller, Leora R Feldstein, Joseph Holbrook, et al.
MMWR. Morbidity and Mortality Weekly Report|September 15, 2022
Pediatric Brain Abscesses, Epidural Empyemas, and Subdural Empyemas Associated with Streptococcus Species - United States, January 2016-August 2022Emma K Accorsi, Sopio Chochua, Heidi L Moline, et al.
MMWR. Morbidity and Mortality Weekly Report|December 1, 2022
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022Ruth Link-Gelles, Allison Avrich Ciesla, Katherine E Fleming-Dutra, et al.
MMWR. Morbidity and Mortality Weekly Report|February 16, 2023
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023Katherine E Fleming-Dutra, Allison Avrich Ciesla, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|February 2, 2023
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, et al.
Nature|May 25, 2022
Discovery of bioactive microbial gene products in inflammatory bowel diseaseYancong Zhang, Amrisha Bhosle, Sena Bae, et al.
Pageof 2